돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 232798생성일: 2026년 10월 26일

Water → 3alpha-(N-[2-Hydroxyethyl]-DL-alanyloxy)-5alpha-pregnan-20-one hydrochloride

https://huagongshe.com/reaction/232798

반응식

참여 물질

역할이름HCID투입량
반응물WaterHCID 962—
반응물TriethylamineHCID 8471—
반응물2-DimethylaminopyridineHCID 21885—
반응물AllopregnanoloneHCID 92786—
반응물2-Bromopropanoyl chlorideHCID 97980—
용매DichloromethaneHCID 6344—
생성물3alpha-(N-[2-Hydroxyethyl]-DL-alanyloxy)-5alpha-pregnan-20-one hydrochlorideHCID 70087260—

반응 단계

A solution of 3α-hydroxy-5α-pregnan-20-one (810 mg, 2.45 mmol) in 100 mL of CH2Cl2 was treated with 2-bromopropionyl chloride (1.0 mL), a catalytic amount of dimethylaminopyridine (50 mg) and triethylamine (2 mL). This mixture was stirred at room temperature for 2.0 h. The crude reaction mixture was poured into water and CH2Cl2. The organic phase was washed several times with 10% HCl, water, saturated aqueous sodium bicarbonate and finally with more water, and dried and evaporated in vacuo. The TLC examination of this material indicated complete conversion of the starting material to bromo ester product (one spot, r.f.=0.9 eluting with Hexane/EtOAc (90:10)). This crude bromo ester in acetonitrile (30 mL) was treated at 0° C. with 2-hydroxyethylamine (2.0 mL) and the mixture stored in the refrigerator overnight. The solvent was removed in vacuo and the residue partitioned between ether and water. The organic phase was separated and extracted with cold 10% HCl. The aqueous acid solution was washed with ether and treated with an excess of aqueous ammonium hydroxide solution at 0° C. The free based product was next extracted into an organic phase with several ether washings. The combined organic phase was concentrated in vacuo and the oily residue dissolved in dioxane and taken to pH 3 with concentrated hydrochloric acid gas dissolved in EtOAc. The mixture was lyophilized and the resulting white amorphous solid taken up in water and the aqueous phase washed with ethyl acetate and ether. The aqueous solution was lyophilized to give the pure title compound (700 mg) as an amorphous solid.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US05591733
출처 데이터셋uspto-grants-1997_01
ORD IDord-80fbdec8534b4f139864847b2a443d64
출처 메모uspto-grants-1997_01